Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best ...

Gilead Sciences, Inc. (GILD) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...
Fierce Biotech

Gilead ends phase 1 trial after settling on twice-yearly treatment partner for lenacapavir

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

SA becomes first African country to register anti-HIV jab Lenacapavir, but what is it and why does it matter?

South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting injectable drug in the fight against HIV/AIDS.